Theravance Biopharma (TBPH) Amortizatization of Intangibles (2015 - 2022)

Theravance Biopharma (TBPH) has 5 years of Amortizatization of Intangibles data on file, last reported at $341000.0 in Q1 2022.

• On a quarterly basis, Amortizatization of Intangibles fell 54.1% year-over-year to $341000.0 in Q1 2022; TTM through Mar 2022 was $3.4 million, a 6.78% decrease from a year earlier, with the FY2021 full-year figure at $3.8 million, up 13.22% from the prior year.
• Amortizatization of Intangibles for Q1 2022 stood at $341000.0, down from $1.0 million in the prior quarter.
• Over the last five years, Amortizatization of Intangibles for TBPH reached as high as $1.1 million in Q4 2020 and fell as low as $195000.0 in Q4 2019.
• Historically, Amortizatization of Intangibles has averaged $822692.3 across 4 years, with a median of $986000.0 in 2019.
• Across the five-year window, Amortizatization of Intangibles jumped 480.0% in 2020 and tumbled 54.1% in 2022, its largest moves.
• Year by year, Amortizatization of Intangibles stood at $195000.0 in 2019, then soared by 480.0% to $1.1 million in 2020, then decreased by 9.11% to $1.0 million in 2021, then slumped by 66.83% to $341000.0 in 2022.
• Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $341000.0 in Q1 2022, $1.0 million in Q4 2021, and $1.0 million in Q3 2021.